Accord Logo

Intended for UK patients and members of the public

PIL- Ambrisentan Accord 5mg, 10mg Film-coated Tablets: Change history

  • Description of update:

    This notification is submitted to amend the packaging components without the need to amend the SmPC. Changes notified are as follows:

    To remove references to EIRE on the PIL as this is no longer a packshare.

    PIL sections updated: 4 and 6.

    • Changes: (Updated: 20 May 2024)

      Description of update:

      This notification is submitted to amend the packaging components without the need to amend the SmPC. Changes notified are as follows:

      To remove references to EIRE on the PIL as this is no longer a packshare.

      PIL sections updated: 4 and 6.

    • Changes: (Updated: 25 May 2023)

      Administrative update only; no changes to file.

    • Changes: (Updated: 25 May 2023)

      Description of update: The proposed change is: C.I.2. a) Implementation of change(s) for which no new additional data is required to be submitted by the MAH. Adaptation of the PI to reference product Volibris. (EMEA/H/C/000839)

      PIL sections updated: 1, 2, 3, 4, 6.

    • Changes: (Updated: 06 Feb 2023)

      Website administration update

    • Changes: (Updated: 20 Sep 2022)

      initial upload

    View product information as a: